ETFIQData as of Nov 18, 2026. · etfiq.com/funds/ijkDownload PDF

IJK Fact Sheet: iShares S&P Mid-Cap 400 Growth ETF

Share
$105.77
close, Nov 18, 2026

Over the year to Nov 18, 2026, IJK returned +14.6% in total and charged 0.16% a year.

1-year total return
+14.6%
MDYG +14.5% to Nov 18, 2026
Expense ratio
0.16%
a year
Net assets
$10.1bn
on Nov 18, 2026
Net flow, last 5 trading days
−$10.9m
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

IJK $11,456 +14.6% · MDYG $11,453 +14.5% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−2.5%
3 months−8.8%
Year to date+9.6%
1 year+14.6%
3 years+47.9%
5 years+27.1%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
UNITED THERAPEUTICS1.53%
TECHNIPFMC PLC1.50%
ATI1.45%
TENET HEALTHCARE CORP1.39%
XPO1.33%
ROYAL GOLD1.30%
ITT INC1.13%
WOODWARD1.12%
NVENT ELECTRIC PLC1.08%
TOAST CLASS A1.06%

IJK top ten by weight, 12.9% of the fund, of its 252 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P MidCap 400 Growth Index · First traded Jul 28, 2000 · Benchmark S&P MidCap 400 Growth Index, measured by MDYG, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, IJK Fact Sheet: iShares S&P Mid-Cap 400 Growth ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/ijk/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/ijk.